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and knee joint replacement as compared with unaffected family con-
trols. On analysing hip and knee radiographs, compared to a combi-
nation of family and population based controls, HBM was associated
with an increased risk of osteophytes, but not joint space narrowing.
Although HBM cases have an increased risk of obesity, these radio-
graphic associations persisted after BMI adjustment. In further analyses
we found that BMD and osteophytes are positively associated with the
presence of radiographic enthesophytes, suggesting a more generalised
tendency towards bone formation (‘bone forming triad’). Taken
together, these ﬁndings suggest that higher BMD has a causal role in
hypertrophic forms of OA, as part of a bony phenotype characterised by
a generalised increase in bone formation. As supported by other evi-
dencewhich suggests that osteophytes directly contribute to pain in OA,
there may be a case for developing speciﬁc therapeutic strategies for
hypertrophic OA.
Targeting the bone phenotype in OA: (i) Biomechanical inputs: Since
osteophytes develop in response to disordered biomechanical inputs,
hypertrophic OA may preferentially respond to biomechanical inter-
ventions such as foot orthoses and muscle strengthening exercises.
(ii) Osteophyte growth: It may be possible to develop drug therapies
which target growth of osteophytes (which arise from the periosteum
and are produced via a process of endochondral bone formation),
without inﬂuencing bone remodelling and affecting the risk of osteo-
porosis. Such an action might explain the beneﬁcial effect of hormone
replacement therapy in OA, given oestrogen suppresses aspects of
endochondral bone formation and selectively inhibits bone formation
at the periosteal surface.
(iii) Nociceptive pathways: Inhibition of inﬂammatory mediators aris-
ing from cartilage, which are thought to contribute to the pathogenesis
of pain in OA, may be of little value in treating hypertrophic forms of the
disease. However, unlike articular cartilage, subchondral bone and
osteophytes are both innervated. Therefore, hypertrophic OA may be
helped by inhibition of neuronal nociceptive pathways, for which a
range of novel inhibitors are in development, intended to target
peripheral pain ﬁbres, spinal cord gate control at the level of the dorsal
root ganglion and/or central pain processing.
Conclusion: Further insights into the molecular processes which reg-
ulate osteophyte development and osteophytic nociception may be
helpful in guiding the development of novel treatments for OA which
act by targeting the bony phenotype.
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GENETIC LINKS BETWEEN DEVELOPMENT AND OSTEOARTHRITIS:
DIO2 GENE AND RISK FOR OSTEOARTHRITIS
I. Meulenbelt. Leiden Univ. Med. Ctr., Leiden, Netherlands
Previously, in the Genetics osteoARthritis and Progression (GARP) study
the deiodinase iodothyronine type II (D2) gene (DIO2) was identiﬁed as
an OA susceptibility gene with this ﬁnding conﬁrmed in other studies
especially, for hip OA in females. D2 is critical in maintaining the
availability of intracellular active thyroid hormone 3,3’,5-triiodothyr-
onine (T3). In the growth plate, T3 initiates the terminal differentiation
of hypertrophic chondrocytes, which is important for the subsequent
formation of long bones. Notably, in end-stage versus non-OA cartilage,
DIO2 expression was found to be highly upregulated whereas an allelic
imbalance was shown for the rs225014 SNP; the mRNAwith the OA risk
allele ‘C’was 30%more abundantly present in articular joint tissues than
the wild-type allele ‘T’. It was then shown that loss of epigenetic
silencing of DIO2 with the OA pathology resulted in a more vivid up
regulation of DIO2 particularly in carriers of this risk allele C. Given the
function of T3 in the growth plate during development, such signalling
in adult articular cartilage is likely detrimental. In this respect, further
studies showed that cartilage speciﬁc induction of DIO2 expression in
adult mice resulted in, OA characteristic, hypertrophic differentiation.
Subsequently, in a human in vitro 3D chondrogenesis model of human
bone-marrow derived mesenchymal stem cells it was shown that up-
regulation of DIO2 expression resulted in a marked reduction in the
capacity of chondrocytes to deposit ECM components, concurrent with
induction of OA-speciﬁc markers of cartilage matrix degeneration and
mineralization. In contrast, inhibition of deiodinases contributed to
prolonged ‘healthy’ cartilage homeostasis by virtue of a denser cartilage
matrix structure with signiﬁcant less cellular lacunae. In line with these
ﬁndings, it was very recent shown that DIO2 knockout mice, have
normal articular cartilage development yet, when subjected to astringent running regime, appear to be protected against cartilage
damage and had reduced severity of synovitis as compared to their wild
type littermates. Together these studies show that loss of epigenetic
control of the DIO2 gene with ongoing OA pathology affects the pro-
pensity of OA chondrocytes recuperate a growth plate morphology and
exhibit debilitating expression. Furthermore, focused functional follow-
up of OA susceptibility genes to elucidate underlying pathophysio-
logical mechanisms may contribute to a desirable translation from
genetic studies towards novel therapeutic options.
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SHOULD OA RESEARCH FOCUS ON “MICE” OR “MEN”?
C.B. Little. Raymond Purves Lab., Kolling Inst., Univ. of Sydney, St.
Leonards, Australia
Purpose: To argue that osteoarthritis (OA) research should focus on
“mice”.
Methods: Review the evidence that real and sustainable advances in
management and treatment of OA in “men” will ultimately come from
“mice”, i.e. preclinical research.
Results: The current model for the discovery, development and trans-
lation of successful therapies for OA into clinical practice has clearly not
been successful. The easy conclusion to drawwould be that what works
in “mice” is not relevant to “men”, and to set aside our preclinical
research efforts. In this presentation we will explore in more depth the
reasons for translational failure in OA, and make the case that far from
cutting preclinical research, we should increase our focus in this area.
Conclusions: Preclinical “mice” research will provide the foundation on
which rational and effective OA treatments in “men” will be based.
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SHOULD OA RESEARCH FOCUS ON “MICE” OR “MEN”?
D.J. Hunter y,z. y Inst. of Bone and Joint Res., Univ. of Sydney, St Leonards,
Australia; zRheumatology Dept., Royal North Shore Hosp., Sydney,
Australia
Purpose: To argue that osteoarthritis research should focus on “men”.
Methods: Provide supportive evidence to support the case that osteo-
arthritis research should focus on human disease. The presentation will
also respond to the arguments made that osteoarthritis research should
focus on mice.
Results: Given the burden of disease in humans and the limited source
of research funding prioritization is required. A case will be made that
too much emphasis is placed on research into mice and insufﬁcient
focus is made on human research.
Conclusions: There is insufﬁcient focus on human research into
osteoarthritis and too great an emphasis is placed on research on mice.
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OSTEOARTHRITIS: INSIGHTS INTO DISEASE INITIATION AND
PROGRESSION FROM MR IMAGING
G. Gold. Stanford Univ. Dept. of Radiology, Stanford, CA, USA
Purpose:Magnetic Resonance Imaging (MRI) has provided researchers
with an opportunity to examine joints non-invasively. Both the mor-
phology and composition of articular cartilage and other tissues can be
measured using MRI. A variety of MRI contrast mechanisms exist that
can give unique information about tissue composition. This information
can gain insight into disease initiation and progression.
Methods: Many different contrast mechanisms are useful with MRI to
examine joint morphology. In general, three-dimensional approaches
are superior for quantitative evaluation of cartilage volume and thick-
ness. Three-dimensional spoiled gradient echo (SPGR, FLASH) with dark
synovial ﬂuid have been used extensively in multiple studies. Other
methods with bright synovial ﬂuid include balanced steady state free
precession (bSSFP), dual-angle steady state (DESS) MRI, and vastly
interpolate projection reconstruction (VIPR). Three-dimensional fast-
spin-echo (3D-FSE) is a new method that may enable cartilage mor-
phology and semi-quantitative scoring of other structures with a single
acquisition. Important in all of these cartilage studies are accurate
image segmentation and registration.
For imaging tissue composition, multiple approaches have proven
useful. The collagen matrix of the cartilage and the meniscus can be
evaluatedwith T2 relaxation timemapping, magnetization transfer, and
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(GAG) matrix in cartilage can be done with delayed gadolinium
enhanced MRI of cartilage (dGEMRIC), T1rho relaxation time meas-
urements, sodium MRI, and chemical exchange saturation transfer
(gagCEST). In addition, evaluation of cartilage and other tissues under
load (biomechanics) is also possible with MRI. All of these method have
advantages and drawbacks that may make them more appropriate to a
given imaging situation or study.
Conclusions: A variety of MRI methods to evaluate a joint with osteo-
arthritis are available. The methods of choice in a particular study
depend on many factors, including hardware available, the joint being
studied, and imaging time. Emphasis will be placed on the trade-offs
between the methods and goals of the imaging study. Study of tissue
composition with MRI may be particularly helpful in disease initiation.
Once OA is established, study of tissue morphology with MRI can be
done quantitatively or with semi-quantitative scoring.
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VALUE OF FUTURE EPIDEMIOLOGIC RESEARCH IN OA: THE ART AND
SCIENCE OF SELECTING AN APPROPRIATE STUDY DESIGN
E. Losina. Boston Univ. Sch. of Publ. Hlth., Boston, MA, USA
During the session we will discuss how to optimize the study design
and to ensure it enables researchers to offer a new informative insight
toward the clinical question under study.Wewill discuss how to choose
among several clinical questions to optimize the likely impact of future
research study. We will address the topics of resource prioritization. In
addition the audience will be introduced to the concept of Value of
Information. We will also cover use and misuse several commonly used
statistical methods in analysis of clinical studies in OA.
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CURRENT STATUS OF THE ART IN COMPOSITIONAL IMAGING OF
JOINT TISSUES
T.M. Link. Univ. of California San Francisco, San Francisco, CA, USA
Purpose: To review technologies currently used to assess the bio-
chemical composition of joint tissues and discuss their pros and cons.
Methods available: During the last decade a number of compositional
technologies have been established and studied mostly using quanti-
tative MRI. These include T2 mapping, T1rho, dGEMRIC (delayed
Gadolinium enhanced MRI of the cartilage), Sodium-23-imaging and
gagCEST (glycosaminoglycan chemical exchange saturation transfer)
imaging to quantify cartilage andmeniscal biochemical composition. T2
mapping is currently the most widely used technology and most
information is available on this imaging biomarker, which provides
quantitative data on water content and collagen integrity of the carti-
lage and menisci. According to previous in vitro studies T1rho charac-
terizes the amount of macromolecules within the tissue, which
correlates with the amount of proteoglycans. dGEMRIC requires the
injection of negatively charged Gadolinium contrast agents which
provide quantitative information on the amount of negatively charged
glycosaminoglycans. Both Sodium imaging and gagCEST target the
concentration of glycosaminoglycans, but require imaging at higher
ﬁeld strength. Quantitative CT has also been used in vivo to assess
glycosaminoglycan concentration in hyaline cartilage but it requires the
injection of contrast agents into the joint and there is radiation
exposure.
Results of previous studies: Previous studies showed that imaging
biomarkers of cartilage composition had good reproducibility and
validated these biomarkers both in an in vitro setting and clinically. In
2011 a multi-center ACRIN trial was published which documented that
in a Multi-Center, Multivendor environment knee cartilage T2, and
patellar T1-rho demonstrated moderate to excellent reproducibility (1).
Similarly phantom measurements over 8 years in the Osteoarthritis
Initiative environment showed good reproducibility of T2 relaxation
times varying from 1.5 to 5.3% (2). Single center studies found good
reproducibilities for dGEMRIC while less consistent data is available for
some the newer techniques such as gagCEST and quantitative CT
arthrography. In vitro studies showed that T1rho, T2 and dGEMRIC
measurements correlated with histological assays of proteoglycan and
collagen as well as mechanical properties of cartilage (3, 4). Clinical
studies documented differences in T1rho, T2 and dGEMRIC measure-
ments between patients with early osteoarthritis and normal controlsand one recent study showed that T2 measurements predicted radio-
graphic onset of knee osteoarthritis in a longitudinal study from the OAI
(5). Longitudinal studies also showed that T2 measurements increased
over time in normal populations, and were sensitive to weight loss and
physical activity. Problems, however, have been found in using meas-
ures of cartilage composition in more advanced degenerative disease.
Conclusion: A number of imaging biomarkers of joint composition are
available, which have been validated and shown to have good repro-
ducibility. T1rho, T2 and dGEMRIC are currently the imaging bio-
markers, which are best established with most studies having been
performed using T2 relaxation time measurements.
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SOXC TRANSCRIPTION FACTORS IN SKELETOGENESIS AND
CARTILAGE DIFFERENTIATION
V. Lefebvre, P. Bhattaram. Cleveland Clinic Lerner Res. Inst., Cleveland, OH,
USA
The healthy development and adult maintenance of the various struc-
tures that make up our skeleton rely on tight coordination of multiple
events. These events include cell fate decisions made by multipotent
mesenchymal progenitor/stem cells and differentiated cell types to
either survive or die, proliferate or growth arrest, migrate or settle, and
maintain stemness or differentiate. These decisions are controlled by
both cell-autonomous and non-cell-autonomous mechanisms, i.e.,
mechanisms dependent on intrinsic properties of cells and on external
cues, respectively. A pivotal decision made by every mesenchymal cell
of the onset of skeletogenesis is to be or not to be a chondrocyte. Sox9
forms with its functional partners, Sox5 and Sox6, a trio of transcription
factors required cell-autonomously for the commitment and differ-
entiation of mesenchymal cells into chondrocytes. In contrast, beta-
catenin is a structural protein and transcriptional co-activator required
to divert cells from the chondrocyte lineage and secure their differ-
entiation into non-chondrocytic cell types. These cell types include
prospective articular joint cells. Antagonism between Sox9 and beta-
catenin thus governs the proper design, development and articulation
of all cartilage templates of future bones. Although it acts cell-autono-
mously, beta-catenin is critically dependent upon canonical Wnt sig-
naling to be stable and thus capable of achieving its functions. This
pathway acts for a large part non-cell-autonomously. As of today, it
remains unknown whether articular progenitor cells and other non-
chondrocytic cell types use cell-autonomous mechanisms to stabilize
beta-catenin and thereby secure their lineage fate. We will show here
that we have newly identiﬁed a distinct trio of Sox proteins that has this
unique property. This trio is composed of Sox4, Sox11, and Sox12, the
three members of the SoxC group. Their inactivation in multipotent
mesenchymal progenitors in the mouse embryo results in a severe
skeletal dysplasia. Cartilage primordia form, but remain tiny and are
fused with each other due to a total absence of articular joints. The SoxC
genes are actively expressed inmesenchymal progenitor cells, including
presumptive joint cells. They have a key role in stabilizing beta-catenin
and thereby in repressing Sox9 expression and securing the non-
chondrocytic fate of the cells. Thus, the SoxC non-chondrocytic trio and
the Sox5/6/9 chondrogenic trio have opposite actions that are necessary
to decide the fate of mesenchymal progenitor/stem cells and thereby
develop a harmonious and fully functional skeleton, including articular
joints.
